Marvell Technology, Inc. — Form 10-Q Summary
Reporting period: Second quarter of fiscal 2022, three months ended July 31, 2021; six-month results compared with the period ended August 1, 2020. Amounts below are in U.S. dollars unless stated otherwise.
Business context and reporting period
Marvell supplies fabless semiconductor solutions for data center, carrier infrastructure, enterprise networking, consumer, and automotive/industrial markets. It completed its acquisition of Inphi on April 20, 2021; reported results include Inphi only from the acquisition date. The company also announced a proposed all-stock acquisition of Innovium on August 3, 2021.
Marvell began presenting revenue by five end markets in Q2 and said it expected to stop reporting revenue by product group beginning in Q3 fiscal 2022.
Financial performance
| Metric | Q2 FY2022 | Q2 FY2021 | Six months FY2022 | Six months FY2021 |
|---|---|---|---|---|
| Revenue | $1,075.9 million | $727.3 million | $1,908.2 million | $1,420.9 million |
| Gross profit | $371.8 million | $359.3 million | $790.0 million | $686.2 million |
| Gross margin | 34.6% | 49.4% | 41.4% | 48.3% |
| Operating loss | $266.7 million | $151.3 million | $349.0 million | $247.3 million |
| Net loss | $276.4 million | $157.9 million | $364.7 million | $270.9 million |
| Diluted loss per share | $0.34 | $0.24 | $0.48 | $0.41 |
- Quarterly revenue rose 47.9% year over year; six-month revenue rose 34.3%. Management attributed growth across all end markets to Inphi and increased product demand. Q2 unit shipments were up 30% and average selling prices up 18% year over year.
- Q2 end-market revenue: data center $433.7 million (+62%); carrier infrastructure $196.7 million (+38%); enterprise networking $222.7 million (+41%); consumer $165.4 million (+23%); automotive/industrial $57.4 million (+125%).
- Gross margin fell 14.8 percentage points in Q2. Management cited acquired-intangible amortization, Inphi inventory fair-value adjustment amortization, and higher product sales. Acquisition-related costs, integration expense, and higher employee costs also increased operating expenses.
- Q2 interest expense was $33.8 million versus $15.6 million a year earlier, primarily reflecting acquisition-related borrowing and newly issued notes. The six-month tax benefit was $53.3 million, including benefits associated with an intellectual-property transfer, stock-based compensation, and tax statute expirations.
Cash flow, debt and liquidity
- For the six months, operating cash flow was $208.4 million, down from $401.5 million. Working capital used $341.2 million, primarily reflecting higher receivables and inventory and lower accrued employee compensation.
- Investing cash outflow was $3.66 billion, including $3.60 billion net cash paid for Inphi. Financing provided $3.27 billion, chiefly from $3.81 billion of debt issuance.
- Cash and cash equivalents were $559.6 million at July 31, 2021, down from $748.5 million at January 30; about $431.8 million was held outside the United States. Management said available cash, operating cash generation, and the revolving facility should cover needs for at least 12 months.
- Debt had a $4.75 billion face value and a $4.70 billion net carrying amount at quarter-end, compared with $1.20 billion face value at January 30. This includes $1.75 billion of term loans and $3.00 billion of senior notes; the $750 million revolving facility was undrawn. The company reported compliance with debt covenants.
- Q2 dividends were $0.06 per share; six-month dividend payments totaled $89.9 million. Share repurchases remained suspended, with $564.5 million of authorization remaining.
Material changes, outlook and risks
- Inphi acquisition: Total merger consideration was approximately $9.92 billion. The acquisition substantially increased goodwill and acquired intangible assets, and added debt. Management described the businesses and product portfolios as complementary, while noting integration and synergy realization risks. Inphi standalone post-acquisition results were not practicable to determine after integration.
- Supply constraints: Industry-wide shortages were limiting Marvell’s ability to meet some demand. A wafer-capacity agreement entails an estimated minimum $770 million of purchases for 2022–2025. A subsequent supplier agreement includes $100 million of refundable deposits and estimated minimum purchases of $1 billion during 2022–2026. Foundry purchase orders outstanding were $775.6 million at quarter-end.
- Outlook: The filing gives no specific revenue or earnings guidance. Management expected supply constraints to continue through calendar 2021 and into 2022, and said U.S. export restrictions on certain Chinese customers would continue to affect fiscal 2022 revenue. The Innovium transaction, estimated at $1.1 billion gross and $955 million net of expected cash and exercise proceeds, was expected to close by calendar year-end 2021, subject to approvals and other conditions.
- Other risks and contingencies: COVID-19, customer order volatility, supply-chain concentration, China trade restrictions, acquisition integration, debt and variable interest rates, tax changes after U.S. domiciliation, product defects, and intellectual-property litigation are highlighted risks. Legal outcomes could not be predicted; management did not expect currently pending matters to have a material adverse effect, but gave no assurance. The company also reported $322.0 million of gross unrecognized tax benefits.
- Management reported disclosure controls were effective as of July 31, 2021 and no material changes to internal control over financial reporting during the quarter.
Most important facts for investors to verify
- How much of revenue growth reflects Inphi consolidation versus underlying demand, and whether Inphi-specific results or synergies become measurable.
- Whether constrained supply, capacity commitments, and related costs affect shipment growth, customer fulfillment, inventory, and gross margin.
- Debt reduction progress, interest expense, covenant headroom, and liquidity following the acquisition financing.
- Whether the proposed Innovium acquisition closes on expected terms and how its stock consideration affects dilution and leverage priorities.
- Exposure to China export controls and customer concentration, including distributor Wintech, which represented 15% of Q2 revenue.
- Whether acquisition-related amortization, inventory fair-value charges, tax benefits, and integration costs materially change reported earnings in subsequent periods.